Article info

Download PDFPDF

Original research
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

Authors

  1. Correspondence to Dr Julia Maria Ressler; julia.ressler{at}meduniwien.ac.at
View Full Text

Citation

Ressler JM, Karasek M, Koch L, et al
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

Publication history

  • Accepted December 22, 2020
  • First published February 19, 2021.
Online issue publication 
February 19, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.